FDA approves laser device to treat nearsightedness

The Food and Drug Administration approved the VisuMax Femtosecond Laser for use in a surgical procedure to reduce or eliminate myopia — nearsightedness — in patients.

Advertisement

The VisuMax Femtosecond Laser uses a very fast, short-pulsed beam to cut a disc-shaped piece of tissue from the cornea, which when removed, changes the shape of the eye to correct myopia. 

In a recent clinical study of 328 patients treated with the device, all but one participant had uncorrected visual acuity of 20/40 or better and 88 percent had acuity of 20/20 or better.  

Dublin, Calif.-based Carl Zeiss Meditec manufactures the device.

More articles on supply chain:

Regional Health wins supply chain performance award
Indiana Blood Center pleads for O-negative donations
Study: Supply chain execs more likely to exhibit psychopathic traits

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.